Fortress Biotech Inc
Research Fortress Biotech Inc (FBIO) on Bullrun: market cap USD 98.00M, P/E 0.9. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerFBIO
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 98.00M
- P/E0.9
- Financial periodFY2025
- RevenueUSD 63.26M
- Revenue growth9.7%
- Net incomeUSD 37.00M
- Gross margin66.9%
Valuation Snapshot
latest market cap is USD 98.00M; P/E is 0.9.
About Fortress Biotech Inc
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea; Qbrexza a medicated cloth towelette for the treatment of axillary hyperhidrosis; Accutane, an oral isotretinoin drug for the treatment of severe recalcitrant nodular acne;
Frequently asked questions
What is Fortress Biotech Inc's market cap?
Fortress Biotech Inc's market capitalization is USD 98.00M.
What is Fortress Biotech Inc's P/E ratio?
Fortress Biotech Inc's price-to-earnings (P/E) ratio is 0.9.
What does Fortress Biotech Inc do?
Fortress Biotech, Inc., together with its subsidiaries, operates as a biopharmaceutical company in the United States and internationally. The company offers Emrosi, a minocycline hydrochloride extended-release capsule for the treatment of rosacea;